Pfizer Says COVID Vaccine for 5- to 11-Year-Olds Is Safe and Shows ‘Robust’ Antibody Response, Experts Say Not So Fast
Pfizer plans to request Emergency Use Authorization from the FDA based on data from its phase 2/3 trial for children ...
Read moreDetails